A Swiss pharmaceutical company is either building a new plant or expanding an existing one here in the US.
This is in response to the Chinese tariffs and not on the Swiss ones.
Interesting.
Even better, getting the production out of China should assist with quality control.
I'd heard rumblings back when my mom worked for Roche that they lost as much to riding their Chinese workers to keep quality up as they saved in cheaper labor.
And that was nearly 30 years ago.
I'm thinking that some companies were itching to make the change and now have the political cover from the US to do so now.
No comments:
Post a Comment
You are a guest here when you comment. This is my soapbox, not yours. Be polite. Inappropriate comments will be deleted without mention. Amnesty period is expired.
Do not go off on a tangent, stay with the topic of the post. If I can't tell what your point is in the first couple of sentences I'm flushing it.
If you're trying to comment anonymously: You can't. Log into your Google account.
If you can't comprehend this, don't comment; because I'm going to moderate and mock you for wasting your time.